Position in ZYME
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$175,280,000
+$23,882,500 QoQ
Shares Held
7,000,000
+21.7% QoQ
Ownership
9.59%
of shares outstanding
% of Portfolio
2.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rubric Capital Management LP holds $938,577,278 across 18 Biotechnology names. ZYME ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $194,878,354 | |
| 2 | ZYME |
Zymeworks Inc.
This page
|
7,000,000 | $175,280,000 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
5,000,000 | $138,500,000 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
8,000,000 | $64,240,000 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
7,000,000 | $60,620,000 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
5,000,000 | $48,600,000 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
427,998 | $45,110,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,712,373 | $44,288,609 |
All Filings in ZYME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $175,280,000 | 7,000,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $175,280,000 | 7,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $151,397,500 | 5,750,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $80,456,211 | 4,710,551 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $59,117,415 | 4,710,551 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,670,868 | 4,338,444 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $57,349,725 | 3,917,331 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $49,162,504 | 3,917,331 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $33,336,486 | 3,917,331 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $36,561,039 | 3,475,384 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $36,109,239 | 3,475,384 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $16,809,837 | 2,651,394 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $20,369,465 | 2,357,577 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $25,806,777 | 2,854,732 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,723,185 | 3,018,217 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||